Table 1. Patients’ characteristics.
| Characteristics | Group 1: ≥5 and <10 cm [88] | Group 2: ≥ 10 cm [39] | Total [127] | P value |
|---|---|---|---|---|
| Age, years mean (range) | 65.8 (35.0–86.0) | 66.6 (38.0–89.0) | 65.5 (35.0–89.0) | 0.272 |
| BMI, mean (range) | 26.4 (15.7–36.3) | 25 (20.2–36.1) | 25.9 (15.7–36.3) | 0.336 |
| Gender, n (%) | 0.146 | |||
| Male | 74 (84.0) | 28 (71.8) | 102 (80.3) | |
| Female | 14 (16.0) | 11 (28.2) | 25 (19.7) | |
| Child-Pugh class, n (%) | 0.552 | |||
| A | 85 (96.6) | 39 (100.0) | 124 (97.6) | |
| B | 3 (3.4) | 0 (0) | 3 (2.4) | |
| MELD score, median (IQR) | 7 (6.0–7.0) | 8 (7.0–8.0) | 8 (7.0–8.0) | 0.449 |
| Underlying aetiology, n (%) | 0.546 | |||
| HBV | 15 (17.0) | 7 (17.9) | 22 (17.3) | |
| HCV | 38 (43.2) | 12 (30.8) | 50 (39.4) | |
| Alcoholic | 4 (4.5) | 3 (7.7) | 7 (5.5) | |
| Cryptogenic | 2 (2.3) | 3 (7.7) | 5 (3.9) | |
| Toxic | 2 (2.3) | 0 (0) | 2 (1.6) | |
| Healthy liver | 27 (30.7) | 14 (35.9) | 41 (32.3) | |
| Alpha fetoprotein (U/L), median (IQR) | 21 (2.5–281.0) | 182 (12.5–1,710.0) | 31 (6.0–798.0) | 0.071 |